Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Reisine

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Faculty Reviews|July 22, 2022
Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeatsJulia Kaye, Terry Reisine, Steven Finkbeiner
Assay and Drug Development Technologies|July 20, 2007
Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screeningRichard M Eglen, Roger Bosse, Terry Reisine
The Journal of Biological Chemistry|June 2, 2024
Three dimensional and four dimensional live imaging to study mechanisms of progressive neurodegenerationJeremy W Linsley, Terry Reisine, Steven Finkbeiner
Combinatorial Chemistry & High Throughput Screening|August 13, 2008
An overview of drug screening using primary and embryonic stem cellsRichard M Eglen, Annette Gilchrist, Terry Reisine
Combinatorial Chemistry & High Throughput Screening|August 13, 2008
The use of immortalized cell lines in GPCR screening: the good, bad and uglyRichard M Eglen, Annette Gilchrist, Terry Reisine
Expert Opinion on Drug Discovery|June 11, 2019
Cell death assays for neurodegenerative disease drug discoveryJeremy W Linsley, Terry Reisine, Steven Finkbeiner
Neuropharmacology|January 22, 2020
Approaches to develop therapeutics to treat frontotemporal dementiaLisa P Elia, Terry Reisine, Amela Alijagic, et al.
Journal of Neurochemistry|June 18, 2002
Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesiclesVivian Y H Hook, Thomas Toneff, Wade Aaron, et al.
Current Chemical Genomics|February 18, 2010
The use of AlphaScreen technology in HTS: current statusRichard M Eglen, Terry Reisine, Philippe Roby, et al.
Biological Chemistry|September 17, 2005
Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's diseaseVivian Hook, Thomas Toneff, Matthew Bogyo, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Faculty Reviews|July 22, 2022
Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeatsJulia Kaye, Terry Reisine, Steven Finkbeiner
Assay and Drug Development Technologies|July 20, 2007
Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screeningRichard M Eglen, Roger Bosse, Terry Reisine
The Journal of Biological Chemistry|June 2, 2024
Three dimensional and four dimensional live imaging to study mechanisms of progressive neurodegenerationJeremy W Linsley, Terry Reisine, Steven Finkbeiner
Combinatorial Chemistry & High Throughput Screening|August 13, 2008
An overview of drug screening using primary and embryonic stem cellsRichard M Eglen, Annette Gilchrist, Terry Reisine
Combinatorial Chemistry & High Throughput Screening|August 13, 2008
The use of immortalized cell lines in GPCR screening: the good, bad and uglyRichard M Eglen, Annette Gilchrist, Terry Reisine
Expert Opinion on Drug Discovery|June 11, 2019
Cell death assays for neurodegenerative disease drug discoveryJeremy W Linsley, Terry Reisine, Steven Finkbeiner
Neuropharmacology|January 22, 2020
Approaches to develop therapeutics to treat frontotemporal dementiaLisa P Elia, Terry Reisine, Amela Alijagic, et al.
Journal of Neurochemistry|June 18, 2002
Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesiclesVivian Y H Hook, Thomas Toneff, Wade Aaron, et al.
Current Chemical Genomics|February 18, 2010
The use of AlphaScreen technology in HTS: current statusRichard M Eglen, Terry Reisine, Philippe Roby, et al.
Biological Chemistry|September 17, 2005
Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's diseaseVivian Hook, Thomas Toneff, Matthew Bogyo, et al.
Pageof 2